UTRN and Duchenne muscular dystrophy: For instance, the common use of mdx/utrophin double mutant mice as a more severe alternative to the mild mdx model of DMD may result in misleading outcomes if used to test therapies, as the probability of patients exhibiting double DGC mutations is extremely low.